Tiagabine hydrochloride is primarily used as an anticonvulsant medication for the treatment of epilepsy. It is specifically prescribed to manage partial seizures in adults and children over the age of 12. The drug works by enhancing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits excessive electrical activity in the brain, thereby reducing the frequency and severity of seizures. It is often used as an adjunctive therapy, meaning it is added to other antiepileptic drugs when they alone are not sufficient to control seizures. Additionally, tiagabine hydrochloride has been explored for its potential in treating other neurological conditions, such as anxiety disorders and neuropathic pain, although these uses are not yet widely established. It is administered orally in tablet form, and dosage is carefully adjusted based on the patient's response and tolerance.